Cite
APA Citation
Steere, B., GOTTLIEB, K., Schmitz, J., Higgs, R., Jia, B., Milch, C., Tuttle, J., Krishnan, V., Belin, R., & Reinisch, W. (n.d.). oP28 Gene expression (GE) values in a phase 2 trial of mirikizumab in ulcerative colitis (UC) correlate better with histopathology (HP) than endoscopy (EN) and Mayo scores. Journal of Crohn's and colitis, 14, S025–S026. http://access.bl.uk/ark:/81055/vdc_100099171488.0x000048